← NDC auxiliary source history
Current NDC auxiliary source rows
Every current FDA unfinished, excluded, package, product, and compounder source row. Empty or malformed identifiers and report-scoped rows remain addressable by their exact source record and row.
Counts come from the five current base tables. The atomic loader verifies that every base source row has exactly one status projection before publication; directory pages use that verified projection and retain exact base-row detail links.
| Exact source record | Source row | Dataset | Record source | Scope | Status | Status meaning | Product NDC | Package NDC | Product / substance | Application | Reporting period | Normalization | Notes | Source date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
outsourcing:2019-1:301 | 301 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride; Ketoprofen; Cyclobenzaprine Hydrochloride; Baclofen; Gabapentin | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:301 | 301 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-1040 | 71266-1040-2 | Dexamethasone Sodium Phosphate | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:301 | 301 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-953 | 69374-953-50 | Dextrose Monohydrate | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:301 | 301 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72833-488 | 72833-488-01 | Dexamethasone Sodium Phosphate | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:301 | 301 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2400 | 72627-2400-1 | Cyanocobalamin | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:301 | 301 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cyclophosphamide | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:301 | 301 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 76154-813 | 76154-813-15 | Epinephrine | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:301 | 301 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-060 | 71506-060-58 | Epinephrine | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:301 | 301 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-1137 | 61141-1137-4 | Ephedrine Sulfate | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:301 | 301 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5091 | 26436-5091-5 | Dimethyl Sulfoxide | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:301 | 301 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6030 | 71285-6030-1 | Epinephrine | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:301 | 301 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71139-5345 | 71139-5345-2 | Epinephrine; Bupivacaine Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:301 | 301 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-050 | 70713-050-01 | Estradiol | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:301 | 301 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-051 | 70713-051-01 | Estradiol | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:301 | 301 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-2080 | 70168-2080-1 | Estradiol | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:302 | 302 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 82396-127 | 82396-127-10 | Esmolol Hydrochloride | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:302 | 302 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Bupivacaine Hydrochloride; Lidocaine Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:302 | 302 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Dexamethasone Sodium Phosphate | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:302 | 302 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0431 | 71285-0431-1 | Dextrose Monohydrate; Leucine; Methionine; Glutamic Acid; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:302 | 302 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Dexamethasone Sodium Phosphate | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:302 | 302 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5575 | 26436-5575-3 | Cyanocobalamin | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:302 | 302 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cyclosporine | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:302 | 302 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 76154-814 | 76154-814-15 | Epinephrine | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:302 | 302 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-7018 | 72196-7018-1 | Epinephrine | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:302 | 302 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-1350 | 61141-1350-5 | Ephedrine Sulfate | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:302 | 302 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Dorzolamide Hydrochloride; Brimonidine Tartrate | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:302 | 302 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 65302-507 | 65302-507-10 | Epinephrine | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:302 | 302 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71139-5350 | 71139-5350-1 | Epinephrine; Bupivacaine Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:302 | 302 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-2050 | 70168-2050-1 | Estradiol | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:302 | 302 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-050 | 70713-050-01 | Estradiol | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:302 | 302 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 79559-3012 | 79559-3012-1 | Estradiol | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:303 | 303 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-975 | 69194-975-10 | 975 EPINEPHRINE 8MG/250ML | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:303 | 303 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Buprenorphine | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:303 | 303 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-075 | 71449-075-32 | Dexamethasone Sodium Phosphate; Bupivacaine Hydrochloride | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:303 | 303 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Diazepam | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:303 | 303 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Dexamethasone Sodium Phosphate | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:303 | 303 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cyanocobalamin | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:303 | 303 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 79926-036 | 79926-036-01 | Cyclosporine | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:303 | 303 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine Bitartrate; Lidocaine; Tetracaine | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:303 | 303 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-7019 | 72196-7019-1 | Epinephrine | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:303 | 303 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9025 | 71266-9025-9 | Ephedrine Sulfate | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:303 | 303 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Dorzolamide Hydrochloride; Brimonidine Tartrate | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:303 | 303 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-8093 | 71285-8093-1 | Epinephrine | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:303 | 303 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-134 | 71449-134-24 | Epinephrine; Bupivacaine Hydrochloride; Dexamethasone Sodium Phosphate | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:303 | 303 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-2030 | 70168-2030-1 | Estradiol | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:303 | 303 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-145 | 70713-145-01 | Estradiol | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:303 | 303 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69761-201 | 69761-201-01 | Estradiol | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:304 | 304 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-023 | 73198-023-10 | SB-4 | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:304 | 304 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Buprenorphine | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:304 | 304 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6555 | 71300-6555-1 | Dexamethasone Sodium Phosphate; Lidocaine Hydrochloride | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:304 | 304 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6573 | 71300-6573-1 | Diclofenac Sodium | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:304 | 304 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-549 | 69374-549-01 | Dexamethasone Sodium Phosphate | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:304 | 304 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5103 | 26436-5103-3 | Cyanocobalamin; Choline Chloride; Thiamine Hydrochloride; Methionine; Inositol; Carnitine; Pyridoxine Hydrochloride | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:304 | 304 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cyclosporine | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:304 | 304 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine Bitartrate; Lidocaine; Tetracaine | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:304 | 304 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71170-060 | 71170-060-05 | Epinephrine Bitartrate; Lidocaine Hydrochloride Anhydrous | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:304 | 304 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 63037-122 | 63037-122-25 | Ephedrine Sulfate | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:304 | 304 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9059 | 83826-9059-2 | Dorzolamide Hydrochloride; Brimonidine Tartrate | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:304 | 304 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-060 | 71506-060-58 | Epinephrine | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:304 | 304 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine; Lidocaine | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:304 | 304 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73693-377 | 73693-377-01 | Estradiol | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:304 | 304 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-148 | 70713-148-01 | Estradiol | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:304 | 304 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69761-181 | 69761-181-01 | Estradiol | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:305 | 305 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-2040 | 70168-2040-1 | E2 15mg | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:305 | 305 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Buprenorphine Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:305 | 305 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Dexamethasone Sodium Phosphate; Moxifloxacin Hydrochloride; Ketorolac Tromethamine | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:305 | 305 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Diethylstilbestrol | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:305 | 305 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-547 | 69374-547-01 | Dexamethasone Sodium Phosphate | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:305 | 305 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cyanocobalamin; Pyridoxine; Succinylcholine Chloride; Methionine; Inositol | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:305 | 305 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cyclosporine | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:305 | 305 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine Bitartrate; Lidocaine; Tetracaine | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:305 | 305 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-121 | 73177-121-19 | Epinephrine Bitartrate; Tetracaine Hydrochloride; Lidocaine Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:305 | 305 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-106 | 73702-106-15 | Ephedrine Sulfate | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:305 | 305 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Dorzolamide Hydrochloride; Brimonidine Tartrate | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:305 | 305 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83298-305 | 83298-305-07 | Epinephrine | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:305 | 305 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine; Lidocaine | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:305 | 305 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73693-370 | 73693-370-01 | Estradiol | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:305 | 305 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-2100 | 70168-2100-1 | Estradiol | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:305 | 305 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69761-061 | 69761-061-01 | Estradiol | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:306 | 306 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6176 | 71285-6176-1 | Vancomycin 1.5gm added to NS | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:306 | 306 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71591-006 | 71591-006-15 | Buprenorphine Hydrochloride | 2019-1 | valid | 0 | 2026-10-15 | |
outsourcing:2019-2:306 | 306 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71591-014 | 71591-014-05 | Dexmedetomidine Hydrochloride | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:306 | 306 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Diethylstilbestrol | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:306 | 306 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Dexamethasone Sodium Phosphate | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:306 | 306 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cyclopentolate Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:306 | 306 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cyclosporine | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:306 | 306 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-121 | 73177-121-24 | Epinephrine Bitartrate; Tetracaine Hydrochloride; Lidocaine Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:306 | 306 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-306 | 69374-306-10 | Epinephrine Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:306 | 306 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-106 | 73702-106-10 | Ephedrine Sulfate | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:306 | 306 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5150 | 26436-5150-1 | Doxycycline Hyclate | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:306 | 306 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-7018 | 71285-7018-1 | Epinephrine | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:306 | 306 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine; Lidocaine Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:306 | 306 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73693-371 | 73693-371-01 | Estradiol | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:306 | 306 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-2060 | 70168-2060-1 | Estradiol | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:306 | 306 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 79559-3006 | 79559-3006-1 | Estradiol | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:307 | 307 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0408 | 72196-0408-1 | Trophamine 4% / Dextrose 10% 250ml in 250ml bag | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:307 | 307 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71591-011 | 71591-011-30 | Buprenorphine Hydrochloride | 2019-1 | valid | 0 | 2026-10-15 | |
outsourcing:2019-2:307 | 307 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Dexpanthenol | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:307 | 307 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Diethylstilbestrol | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:307 | 307 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-1040 | 71266-1040-2 | Dexamethasone Sodium Phosphate | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:307 | 307 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cyclopentolate Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:307 | 307 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cyclosporine | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:307 | 307 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-121 | 73177-121-19 | Epinephrine Bitartrate; Tetracaine Hydrochloride; Lidocaine Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:307 | 307 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine Hydrochloride; Lidocaine Hydrochloride | 2022-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-1:307 | 307 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72055-003 | 72055-003-01 | Ephedrine Sulfate | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:307 | 307 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2358 | 72934-2358-2 | Econazole Nitrate; Niacinamide | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:307 | 307 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-7019 | 71285-7019-1 | Epinephrine | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:307 | 307 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5311 | 26436-5311-1 | Epinephrine; Tetracaine; Lidocaine Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:307 | 307 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70713-051 | 70713-051-01 | Estradiol | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:307 | 307 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-2090 | 70168-2090-1 | Estradiol | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:307 | 307 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 79559-3015 | 79559-3015-1 | Estradiol | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:308 | 308 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 79559-6100 | 79559-6100-1 | S-TT100 | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:308 | 308 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71591-011 | 71591-011-60 | Buprenorphine Hydrochloride | 2019-1 | valid | 0 | 2026-10-15 | |
outsourcing:2019-2:308 | 308 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2412 | 72627-2412-1 | Dexpanthenol | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:308 | 308 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-541 | 70004-541-35 | Diltiazem Hydrochloride | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:308 | 308 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-075 | 71449-075-32 | Dexamethasone Sodium Phosphate; Bupivacaine Hydrochloride | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:308 | 308 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-0859 | 5446-0859-03 | Cyclopentolate Hydrochloride; Phenylephrine Hydrochloride; Tropicamide; Ketorolac Tromethamine | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:308 | 308 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 79926-002 | 79926-002-01 | Cyclosporine | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:308 | 308 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-544 | 69374-544-10 | Epinephrine Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:308 | 308 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-134 | 71449-134-32 | Epinephrine; Bupivacaine Hydrochloride; Dexamethasone Sodium Phosphate | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:308 | 308 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2023-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-2:308 | 308 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83343-004 | 83343-004-15 | Edetate Calcium Disodium Trihydrate | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:308 | 308 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:308 | 308 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0050 | 73271-0050-1 | Estradiol | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:308 | 308 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0010 | 73271-0010-1 | Estradiol | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:308 | 308 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-2050 | 70168-2050-1 | Estradiol | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:308 | 308 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 79559-3037 | 79559-3037-1 | Estradiol | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:309 | 309 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 83556-0422 | 83556-0422-2 | Ceftazidime 22.5mg/mL | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:309 | 309 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71591-003 | 71591-003-60 | Buprenorphine Hydrochloride | 2019-1 | valid | 0 | 2026-10-15 | |
outsourcing:2019-2:309 | 309 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Dexpanthenol | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:309 | 309 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-540 | 70004-540-35 | Diltiazem Hydrochloride | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:309 | 309 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6555 | 71300-6555-1 | Dexamethasone Sodium Phosphate; Lidocaine Hydrochloride | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:309 | 309 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-0993 | 5446-0993-01 | Cyclopentolate Hydrochloride; Phenylephrine Hydrochloride; Tropicamide; Ketorolac Tromethamine | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:309 | 309 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 79926-003 | 79926-003-01 | Cyclosporine | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:309 | 309 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine Hydrochloride; Lidocaine Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:309 | 309 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine; Lidocaine | 2022-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-1:309 | 309 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9027 | 71266-9027-1 | Ephedrine Sulfate | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:309 | 309 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5557 | 26436-5557-1 | Edetate Disodium | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:309 | 309 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:309 | 309 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0010 | 73271-0010-1 | Estradiol | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:309 | 309 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0125 | 73271-0125-1 | Estradiol | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:309 | 309 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-2030 | 70168-2030-1 | Estradiol | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:309 | 309 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69761-251 | 69761-251-01 | Estradiol | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:310 | 310 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-6076 | 71285-6076-1 | Vancomycin 1.5gm added to NS | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:310 | 310 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71591-003 | 71591-003-30 | Buprenorphine Hydrochloride | 2019-1 | valid | 0 | 2026-10-15 | |
outsourcing:2019-2:310 | 310 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Dexpanthenol | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:310 | 310 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70324-976 | 70324-976-01 | Diltiazem Hydrochloride | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:310 | 310 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Dexamethasone Sodium Phosphate; Moxifloxacin Hydrochloride; Ketorolac Tromethamine | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:310 | 310 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cyclopentolate Hydrochloride; Tropicamide; Phenylephrine Hydrochloride | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:310 | 310 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 79926-001 | 79926-001-01 | Cyclosporine | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:310 | 310 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-134 | 71449-134-32 | Epinephrine; Bupivacaine Hydrochloride; Dexamethasone Sodium Phosphate | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:310 | 310 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine; Lidocaine Hydrochloride | 2022-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-1:310 | 310 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2023-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-2:310 | 310 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5023 | 26436-5023-5 | Edetate Disodium | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:310 | 310 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-977 | 69194-977-10 | Epinephrine | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:310 | 310 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0125 | 73271-0125-1 | Estradiol | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:310 | 310 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0006 | 73271-0006-1 | Estradiol | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:310 | 310 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-3712 | 72682-3712-1 | Estradiol | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:310 | 310 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69761-121 | 69761-121-01 | Estradiol | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:311 | 311 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-158 | 73198-158-30 | Magnesium Chloride 300 mg/mL | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:311 | 311 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71591-015 | 71591-015-30 | Buprenorphine Hydrochloride | 2019-1 | valid | 0 | 2026-10-15 | |
outsourcing:2019-2:311 | 311 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Dexpanthenol | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:311 | 311 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70324-951 | 70324-951-01 | Diltiazem Hydrochloride | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:311 | 311 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Dexmedetomidine Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:311 | 311 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cyclophosphamide | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:311 | 311 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 79926-005 | 79926-005-01 | Cyclosporine | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:311 | 311 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-127 | 71449-127-32 | Epinephrine; Bupivacaine Hydrochloride; Dexamethasone Sodium Phosphate | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:311 | 311 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine; Lidocaine Hydrochloride | 2022-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-1:311 | 311 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2023-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-2:311 | 311 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Hydrochloride | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:311 | 311 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-944 | 69194-944-01 | Epinephrine | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:311 | 311 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73693-378 | 73693-378-01 | Estradiol | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:311 | 311 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0018 | 73271-0018-1 | Estradiol | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:311 | 311 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-3715 | 72682-3715-1 | Estradiol | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:311 | 311 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69761-101 | 69761-101-01 | Estradiol | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:312 | 312 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5101 | 26436-5101-3 | Glutamine 25mg/mL | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:312 | 312 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Buprenorphine Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:312 | 312 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Dexpanthenol; Pyridoxine | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:312 | 312 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1086 | 5446-1086-03 | Diltiazem Hydrochloride | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:312 | 312 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71449-131 | 71449-131-11 | Dexmedetomidine Hydrochloride | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:312 | 312 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cyclophosphamide | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:312 | 312 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cyclosporine | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:312 | 312 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Epinephrine; Lidocaine Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:312 | 312 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-099 | 73198-099-30 | Epinephrine; Lidocaine Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:312 | 312 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-477 | 70092-477-44 | Ephedrine Sulfate | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:312 | 312 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ephedrine Sulfate | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:312 | 312 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-976 | 69194-976-10 | Epinephrine | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:312 | 312 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73693-373 | 73693-373-01 | Estradiol | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:312 | 312 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73271-0050 | 73271-0050-1 | Estradiol | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:312 | 312 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73693-378 | 73693-378-01 | Estradiol | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:312 | 312 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69761-151 | 69761-151-01 | Estradiol | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:313 | 313 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-8106 | 70168-8106-1 | Testosterone 87.5mg | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:313 | 313 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Buprenorphine Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:313 | 313 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Dextrose | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:313 | 313 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Diltiazem Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:313 | 313 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Dexmedetomidine Hydrochloride | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:313 | 313 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cyclophosphamide | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:313 | 313 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Cyclosporine | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:313 | 313 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-6276 | 71266-6276-3 | Epinephrine; Lidocaine Hydrochloride; Tetracaine Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:313 | 313 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-2040 | 70168-2040-1 | Estradiol | 2022-2 | valid | 0 | 2026-10-15 |